Evaluation of NTP42 , a novel thromboxane receptor antagonist, in a first-in-human phase I clinical trial
Reid, Helen M, Maginn, Mark, Perkins, C Michael, Mulvaney, Eamon P, Boyce, Malcolm, Yamamoto, Takahiro, Kinsella, B Therese
Published in Frontiers in pharmacology (21.12.2023)
Published in Frontiers in pharmacology (21.12.2023)
Get full text
Journal Article
Caffeine induces a profound and persistent tachycardia in response to MDMA (“Ecstasy”) administration
McNamara, Ruth, Maginn, Mark, Harkin, Andrew
Published in European journal of pharmacology (26.01.2007)
Published in European journal of pharmacology (26.01.2007)
Get full text
Journal Article
Comparison of anaesthetised and conscious rat model for the early evaluation of myocardial contractility
Delpy, Eric, Hirel, Rögis, Infanti, Fabrice, la Rochelle, Christophe Drieu, Maginn, Mark
Published in Journal of pharmacological and toxicological methods (01.10.2008)
Published in Journal of pharmacological and toxicological methods (01.10.2008)
Get full text
Journal Article
The effect of 2-amino-3-phosphonopropionic acid (AP-3) in the gerbil model of cerebral ischaemia
Maginn, Mark, Caldwell, Maeve, Kelly, J.P., Leonard, B.E.
Published in European journal of pharmacology (25.08.1995)
Published in European journal of pharmacology (25.08.1995)
Get full text
Journal Article